I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe

scientific article (publication date: 2011)

I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2011PLoSO...627622K
P356DOI10.1371/JOURNAL.PONE.0027622
P3181OpenCitations bibliographic resource ID3278035
P932PMC publication ID3216983
P698PubMed publication ID22110695
P5875ResearchGate publication ID51824234

P50authorPedro PechirraQ55207385
Daniela PitigoiQ56486864
Silvia Jiménez-JorgeQ56486868
Jean-Marie CohenQ88140801
Isabelle DaviaudQ126616297
Thomas SeylerQ29056947
Caterina RizzoQ37366708
Amparo LarrauriQ41928148
Baltazar NunesQ42233620
P2093author name stringPawel Stefanoff
Alain Moren
Alina Elena Ivanciuc
Anne-Sophie Barret
Beatrix Oroszi
Bruno Christian Ciancio
Camelia Savulescu
Esther Kissling
Iwona Anna Paradowska-Stankiewicz
Joan O'Donnell
Judit Krisztina Horvath
Marta Valenciano
P2860cites workEffectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysisQ95458203
Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control studyQ21144621
Assessing heterogeneity in meta-analysis: Q statistic or I2 index?Q29619545
First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States.Q30372912
"I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9.Q30382891
Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.Q30398764
Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11.Q30399830
Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control studyQ30401132
Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.Q30404419
Two-stage methods for the analysis of pooled dataQ30655622
Multiple imputation for missing data in epidemiological and clinical research: potential and pitfallsQ33476068
Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study.Q44222661
Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009Q45167855
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 seasonQ46159620
Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networksQ50129178
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectvaccineQ134808
influenza vaccineQ383260
P304page(s)e27622
P577publication date2011-01-01
P1433published inPLOS OneQ564954
P1476titleI-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe
P478volume6

Reverse relations

cites work (P2860)
Q346579592011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a European network of hospitals. A pilot study.
Q34076633Annual public health and economic benefits of seasonal influenza vaccination: a European estimate
Q35211657Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany
Q36957563Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States
Q34532079Available influenza vaccines: immunization strategies, history and new tools for fighting the disease
Q38824484Beliefs and attitudes towards the influenza vaccine in high-risk individuals.
Q30367464Can the rolling cross-sectional survey design be used to estimate the effectiveness of influenza vaccines?
Q39530697Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011.
Q38819920Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review
Q41732569Cost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in Belgium.
Q34071701Costs and benefits of influenza vaccination: more evidence, same challenges
Q35956533Detailed Report on 2014/15 Influenza Virus Characteristics, and Estimates on Influenza Virus Vaccine Effectiveness from Austria's Sentinel Physician Surveillance Network
Q41727440Detection of Influenza and Other Respiratory Viruses Carried Out in the Influenza Project - Monitoring Vaccine Effectiveness (I-MOVE).
Q36887954Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V ® and Fluad ® ) in preventing hospitalization for influenza and pneumonia in the elderly: a matched case-control study
Q34993133Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination
Q42228543Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010-2012.
Q30367263Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009-2010 and 2010-2011 in Finland.
Q31161295Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies
Q36251706Effectiveness of seasonal influenza vaccine in preventing medically attended influenza infection in England and Wales during the 2010/2011 season: a primary care-based cohort study
Q30420024Effectiveness of seasonal influenza vaccines against influenza-associated illnesses among US military personnel in 2010-11: a case-control approach
Q30428316Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study
Q46200283Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season
Q34786909Field seasonal influenza vaccine effectiveness: evaluation of the screening method using different sources of data during the 2010/2011 French influenza season
Q27009478Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults
Q33891510Geographical heterogeneity and influenza infection within households
Q39813822I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?
Q36946436Immunogenicity and Efficacy of A/H1N1pdm Vaccine Among Subjects With Severe Motor and Intellectual Disability in the 2010/11 Influenza Season
Q36115609Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine
Q30383312Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.
Q90246622Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease
Q56791503Influenza Vaccine Effectiveness in Preventing Outpatient, Inpatient, and Severe Cases of Laboratory-Confirmed Influenza
Q42872289Influenza Vaccine Effectiveness: Mysteries, Enigmas, and a Few Clues
Q34850986Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study
Q42187912Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012.
Q41612054Influenza vaccine effectiveness estimates in Croatia in 2010-2011: a season with predominant circulation of A(H1N1)pdm09 influenza virus
Q38835739Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups
Q40765540Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season.
Q33554684Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates
Q36956943Influenza vaccine effectiveness in the community and the household
Q41934389Influenza vaccine use to protect healthy children: A debated topic
Q42237299Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014.
Q42203352Is the adjuvanted influenza vaccine more effective than the trivalent inactivated vaccine in the elderly population? Results of a case-control study
Q36343637Is the impact of childhood influenza vaccination less than expected: a transmission modelling study
Q36148024Long-Term Correlation between Influenza Vaccination Coverage and Incidence of Influenza-Like Illness in 14 European Countries
Q44243917Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011.
Q39422605Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan
Q38907201Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies
Q34778408Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review
Q40143693Regression approaches in the test-negative study design for assessment of influenza vaccine effectiveness.
Q40042673Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory Confirmed Influenza in 2014-2015 season in Turkey: A Test-Negative Case Control Study.
Q42235495Seasonal influenza vaccine effectiveness against influenza in 2012-2013: a hospital-based case-control study in Lithuania
Q30383722Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach
Q41053372Social class based on occupation is associated with hospitalization for A(H1N1)pdm09 infection. Comparison between hospitalized and ambulatory cases.
Q41263011The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
Q90692852The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology
Q37260000The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings
Q51225150The case test-negative design for studies of the effectiveness of influenza vaccine.
Q30371807Use of neuraminidase inhibitors in primary health care during pandemic and seasonal influenza between 2009 and 2013
Q37111637Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season
Q24201525Vaccines for preventing influenza in healthy children
Q47638511Vaccines for preventing influenza in healthy children
Q45760952Variable definitions of the influenza season and their impact on vaccine effectiveness estimates
Q38803189Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies
Q93344976[The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment]

Search more.